P63
p63,亦作TP63,全称肿瘤蛋白p63(tumor protein p63)或恶性转化相关蛋白63(transformation-related protein 63),在人体内由TP63基因编码[6][7][8][9]。p63的发现是在p53基因发现后20年。p63与p53、p73同属一个蛋白家族,三者结构与功能都较为相似[10]。尽管p63的发现晚于p53,但进化生物学的证据表明p63是p53蛋白家族的起源,p53、p73都是由p63蛋白演化而成[11]。
功能
p63是p53蛋白家族下的一种转录因子。p63-/-基因型的小鼠会出现无牙、乳腺等发育依赖间充质-上皮相互作用的器官组织及无附肢等多种发育缺陷。p63蛋白的转录变体主要有两种,TAp63和ΔNp63。已证明ΔNp63拥有多种功能,包括参与皮肤发育和成体干细胞/祖细胞的功能调控[12]。相比之下,传统的观点认为TAp63的功能几乎只局限于参与凋亡过程。不过,近期的研究还表明TAp63参与了卵母细胞完整性的维持[13]。另一些研究还表明TAp63参与了心脏发育[14]和早衰过程[15]。
临床意义
p63蛋白的突变可能会导致兔唇、腭裂等发育畸形[16]。p63蛋白的突变可导致以等裂兔唇为典型特征的EEC综合征(ectrodactyly-ectodermal dysplasia-cleft syndrom)[16]。此外,p63蛋白的突变也可能导致3型兔唇腭裂综合征(EEC3)、先天性缺指(ectrodactyly,亦称为裂手-脚畸形4),以及以等裂兔唇为典型特征的AEC综合征[16]。此外,ADULT综合征(Acro–dermato–ungual–lacrimal–tooth syndrome)、附肢-乳腺综合征(limb-mammary syndrome)、RHS综合征(Rap-Hodgkin syndrome)以及也与p63蛋白功能的异常有关。目前认为兔唇、腭裂是同时出现还是任出现一种取决于p63的不同突变[16]近期,研究人员提出使用iPS细胞分化替代缺陷型上皮细胞治疗EEC综合征的方法[17]。
诊断
p63的免疫组化法可以用于诊断扁平细胞癌和前列腺腺癌(最常见的一种前列腺癌)[18]。正常的前列腺腺体含有基底细胞,因而组织高表达p63,免疫染色深,而恶性转化后的腺癌组织因缺少基底细胞,p63免疫染色呈现阴性结果[19]。p63亦可用于鉴别腺癌、小细胞癌中常见的分化程度低的癌变扁平细胞[20]。
参见
- AMACR,另一种前列腺癌的肿瘤标志物
参考文献
- .
- GRCh38: Ensembl release 89: ENSG00000073282 - Ensembl, May 2017
- GRCm38: Ensembl release 89: ENSMUSG00000022510 - Ensembl, May 2017
- . National Center for Biotechnology Information, U.S. National Library of Medicine.
- . National Center for Biotechnology Information, U.S. National Library of Medicine.
- Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D, McKeon F. . Molecular Cell. Sep 1998, 2 (3): 305–16. PMID 9774969. doi:10.1016/S1097-2765(00)80275-0.
- Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, Ikawa Y, Nimura Y, Nakagawara A, Obinata M, Ikawa S. . Nature Medicine. Jul 1998, 4 (7): 839–43. PMID 9662378. doi:10.1038/nm0798-839.
- Zeng X, Zhu Y, Lu H. . Carcinogenesis. Feb 2001, 22 (2): 215–9. PMID 11181441. doi:10.1093/carcin/22.2.215.
- Tan M, Bian J, Guan K, Sun Y. . Carcinogenesis. Feb 2001, 22 (2): 295–300. PMID 11181451. doi:10.1093/carcin/22.2.295.
- Wu G, Nomoto S, Hoque MO, Dracheva T, Osada M, Lee CC, Dong SM, Guo Z, Benoit N, Cohen Y, Rechthand P, Califano J, Moon CS, Ratovitski E, Jen J, Sidransky D, Trink B. . Cancer Research. May 2003, 63 (10): 2351–7. PMID 12750249.
- Skipper M. . Nature Reviews Molecular Cell Biology. January 2007, 8 (1): 4–5. doi:10.1038/nrm2091.
- Crum CP, McKeon FD. . Annual Review of Pathology. 2010, 5: 349–71. PMID 20078223. doi:10.1146/annurev-pathol-121808-102117.
- Deutsch GB, Zielonka EM, Coutandin D, Weber TA, Schäfer B, Hannewald J, Luh LM, Durst FG, Ibrahim M, Hoffmann J, Niesen FH, Sentürk A, Kunkel H, Brutschy B, Schleiff E, Knapp S, Acker-Palmer A, Grez M, McKeon F, Dötsch V. . Cell. Feb 2011, 144 (4): 566–76. PMC 3087504
. PMID 21335238. doi:10.1016/j.cell.2011.01.013.
- Rouleau M, Medawar A, Hamon L, Shivtiel S, Wolchinsky Z, Zhou H, De Rosa L, Candi E, de la Forest Divonne S, Mikkola ML, van Bokhoven H, Missero C, Melino G, Pucéat M, Aberdam D. . Stem Cells. Nov 2011, 29 (11): 1672–83 [2017-11-13]. PMID 21898690. doi:10.1002/stem.723. (原始内容存档于2014-08-08).
- Su X, Paris M, Gi YJ, Tsai KY, Cho MS, Lin YL, Biernaskie JA, Sinha S, Prives C, Pevny LH, Miller FD, Flores ER. . Cell Stem Cell. Jul 2009, 5 (1): 64–75. PMC 3418222
. PMID 19570515. doi:10.1016/j.stem.2009.04.003.
- Dixon MJ, Marazita ML, Beaty TH, Murray JC. . Nature Reviews Genetics. Mar 2011, 12 (3): 167–78. PMC 3086810
. PMID 21331089. doi:10.1038/nrg2933.
- Shalom Feuerstein R. et al. Impaired epithelial differentiation of induced pluripotent stem cells from EEC patients is rescued by APR-246/PRIMA-1MET. P.N.A.S 2012. . [2014-12-13]. (原始内容存档于2014-12-14).
- Shiran MS, Tan GC, Sabariah AR, Rampal L, Phang KS. . The Medical Journal of Malaysia. Mar 2007, 62 (1): 36–9. PMID 17682568.
- Herawi M, Epstein JI. . The American Journal of Surgical Pathology. Jun 2007, 31 (6): 889–94. PMID 17527076. doi:10.1097/01.pas.0000213447.16526.7f.
- Zhang H, Liu J, Cagle PT, Allen TC, Laga AC, Zander DS. . Modern Pathology. Jan 2005, 18 (1): 111–8. PMID 15309021. doi:10.1038/modpathol.3800251.
- Fomenkov A, Huang YP, Topaloglu O, Brechman A, Osada M, Fomenkova T, Yuriditsky E, Trink B, Sidransky D, Ratovitski E. . The Journal of Biological Chemistry. Jun 2003, 278 (26): 23906–14. PMID 12692135. doi:10.1074/jbc.M300746200.
- Yi R, Poy MN, Stoffel M, Fuchs E. . Nature. Mar 2008, 452 (7184): 225–9. PMID 18311128. doi:10.1038/nature06642.
- Aberdam D, Candi E, Knight RA, Melino G. . Trends in Biochemical Sciences. Dec 2008, 33 (12): 583–91 [2017-11-13]. PMID 18848452. doi:10.1016/j.tibs.2008.09.002. (原始内容存档于2013-04-21).
拓展阅读
- Little NA, Jochemsen AG. . The International Journal of Biochemistry & Cell Biology. Jan 2002, 34 (1): 6–9. PMID 11733180. doi:10.1016/S1357-2725(01)00086-3.
- van Bokhoven H, McKeon F. . Trends in Molecular Medicine. Mar 2002, 8 (3): 133–9. PMID 11879774. doi:10.1016/S1471-4914(01)02260-2.
- van Bokhoven H, Brunner HG. . American Journal of Human Genetics. Jul 2002, 71 (1): 1–13. PMC 384966
. PMID 12037717. doi:10.1086/341450.
- Brunner HG, Hamel BC, van Bokhoven H. . American Journal of Medical Genetics. Oct 2002, 112 (3): 284–90. PMID 12357472. doi:10.1002/ajmg.10778.
- Jacobs WB, Walsh GS, Miller FD. . The Neuroscientist. Oct 2004, 10 (5): 443–55. PMID 15359011. doi:10.1177/1073858404263456.
- Zusman I. . In Vivo. 2005, 19 (3): 591–8. PMID 15875781.
- Morasso MI, Radoja N. . Birth Defects Research. Part C, Embryo Today. Sep 2005, 75 (3): 163–71. PMC 1317295
. PMID 16187309. doi:10.1002/bdrc.20047.
- Barbieri CE, Pietenpol JA. . Experimental Cell Research. Apr 2006, 312 (6): 695–706. PMID 16406339. doi:10.1016/j.yexcr.2005.11.028.
- Shalom-Feuerstein R, Lena AM, Zhou H, De La Forest Divonne S, Van Bokhoven H, Candi E, Melino G, Aberdam D. . Cell Death and Differentiation. May 2011, 18 (5): 887–96. PMC 3131930
. PMID 21127502. doi:10.1038/cdd.2010.159.